Clinical study design

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Clinical study design is the formulation of trials and experiments, as well as observational studies in medical, clinical and other types of research (e.g., epidemiological) involving human beings.[1] The goal of a clinical study is to assess the safety, efficacy, and / or the mechanism of action of an investigational medicinal product or procedure, or new drug or device that is in development, but potentially not yet approved by a health authority (e.g. Food and Drug Administration).[2] It can also be to investigate a drug, device or procedure that has already been approved but is still in need of further investigation, typically with respect to long-term effects or cost-effectiveness.[3]

Some of the considerations here are shared under the more general topic of design of experiments but there can be others, in particular related to patient confidentiality and ethics.

Outline of types of designs for clinical studies[edit]

Treatment studies[edit]

Observational studies[edit]

1. Descriptive

2. Analytical

Important considerations[edit]

When choosing a study design, many factors must be taken into account. Different types of studies are subject to different types of bias. For example, recall bias is likely to occur in cross-sectional or case-control studies where subjects are asked to recall exposure to risk factors. Subjects with the relevant condition (e.g. breast cancer) may be more likely to recall the relevant exposures that they had undergone (e.g. hormone replacement therapy) than subjects who don't have the condition.

The ecological fallacy may occur when conclusions about individuals are drawn from analyses conducted on grouped data. The nature of this type of analysis tends to overestimate the degree of association between variables.

Seasonal studies[edit]

Conducting studies in seasonal indications (such as allergies, Seasonal Affective Disorder, influenza, and others) can complicate a trial as patients must be enrolled quickly. Additionally, seasonal variations and weather patterns can affect a seasonal study.[14][15]

Other terms[edit]

  • The term retrospective study is sometimes used as another term for a case-control study.[16] This use of the term "retrospective study" is misleading, however, and should be avoided because other research designs besides case-control studies are also retrospective in orientation.[citation needed]
  • Superiority trials are designed to demonstrate that one treatment is more effective than a given reference treatment. This type of study design is often used to test the effectiveness of a treatment compared to placebo or to the currently best available treatment.
  • Non-inferiority trials are designed to demonstrate that a treatment is at least not appreciably less effective than a given reference treatment. This type of study design is often employed when comparing a new treatment to an established medical standard of care, in situations where the new treatment is cheaper, safer or more convenient than the reference treatment and would therefore be preferable if not appreciably less effective.
  • Equivalence trials are designed to demonstrate that two treatments are equally effective.
  • When using "parallel groups", each patient receives one treatment; in a "crossover study", each patient receives several treatments but in different order.
  • A longitudinal study assesses research subjects over two or more points in time; by contrast, a cross-sectional study assesses research subjects at only one point in time (so case-control, cohort, and randomized studies are not cross-sectional).

See also[edit]

References[edit]

  1. ^ Miquel Porta (2014) "A dictionary of epidemiology", 6th edn, New York: Oxford University Press. ISBN 9780199976737.
  2. ^ Ann (April 14, 2006). "Clinical Study Management". ProMedica International. Retrieved June 4, 2019.
  3. ^ Nichols, Hannah (May 18, 2018). "How do clinical trials work and who can participate?". Medical News Today. Retrieved June 4, 2019.
  4. ^ Shiel Jr., William C. (December 21, 2018). "Randomized control trial". Medicine Net. Retrieved June 4, 2019.
  5. ^ "Are these data real? Statistical methods for the detection of data fabrication in clinical trials". The BMJ. July 28, 2005. Retrieved June 4, 2019.
  6. ^ Shiel Jr., William C. (December 21, 2018). "Nonblinded study". Medicine Net. Retrieved June 4, 2019.
  7. ^ Mahajan, Rajiv; Gupta, Kapil (August 2012). "Adaptive design clinical trials: Methodology, challenges and prospect". Indian Journal of Pharmacology. 42: 201–7. doi:10.4103/0253-7613.68417. PMC 2941608. PMID 20927243.
  8. ^ "NCI Dictionary of Cancer Terms". National Cancer Institute. Retrieved June 4, 2019.
  9. ^ "Regression based quasi-experimental approach when randomisation is not an option: interrupted time series analysis". The BMJ. June 9, 2015. Retrieved June 4, 2019.
  10. ^ a b Mathes, Tim; Pieper, Dawid (July 17, 2017). "Clarifying the distinction between case series and cohort studies in systematic reviews of comparative studies: potential impact on body of evidence and workload". BMC Med Res Methodol. 17: 107. doi:10.1186/s12874-017-0391-8. PMC 5513097. PMID 28716005.
  11. ^ "NCI Dictionary of Cancer Terms". National Cancer Institute. Retrieved June 4, 2019.
  12. ^ "NCI Dictionary of Cancer Terms". National Cancer Institute. Retrieved June 4, 2019.
  13. ^ "NCI Dictionary of Cancer Terms". National Cancer Institute. Retrieved June 4, 2019.
  14. ^ Yamin Khan; Sarah Tilly. "Flu, Season, Diseases Affect Trials". Applied Clinical Trials Online. Archived from the original on 11 July 2011. Retrieved 26 February 2010.
  15. ^ Yamin Khan; Sarah Tilly. "Seasonality: The Clinical Trial Manager's Logistical Challenge" (PDF). published by: Pharm-Olam International (POI). Archived from the original (PDF) on 15 July 2011. Retrieved 26 April 2010.
  16. ^ "Prospective vs. Retrospective Studies". Stats Direct. Retrieved May 30, 2019.

External links[edit]